Health Insurance Instability Following Firearm Injury

George Karandinos(Harvard University), Zirui Song(Nanjing Normal University), Chana A. Sacks(Harvard University), Peter T. Masiakos(Massachusetts General Hospital), Mia Giuriato(Dana-Farber/Harvard Cancer Center)
Annals of Surgery
February 19, 2025
10.1097/sla.0000000000006675
Cited by 1

Related Papers

Efficacy of Tocilizumab in Patients Hospitalized with Covid-19
|New England Journal of Medicine|2020|1.4k
Human ovarian cancer, cell lines, and primary ascites cells express the human Mullerian inhibiting substance (MIS) type II receptor, bind, and are responsive to MIS.
|PubMed|1999|122
Paradigm Shifts in Heart-Failure Therapy — A Timeline
|New England Journal of Medicine|2014|114
Müllerian Inhibiting Substance Inhibits Ovarian Cell Growth through an Rb-independent Mechanism
|Journal of Biological Chemistry|2000|86
Oral Anticoagulant Utilization in the United States and United Kingdom
|Journal of General Internal Medicine|2020|79